Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial J Bruix, S Qin, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, ... The Lancet 389 (10064), 56-66, 2017 | 3482 | 2017 |
Pig liver sausage as a source of hepatitis E virus transmission to humans P Colson, P Borentain, B Queyriaux, M Kaba, V Moal, P Gallian, L Heyries, ... The Journal of infectious diseases 202 (6), 825-834, 2010 | 795 | 2010 |
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma … V Vilgrain, H Pereira, E Assenat, B Guiu, AD Ilonca, GP Pageaux, A Sibert, ... The Lancet Oncology 18 (12), 1624-1636, 2017 | 770 | 2017 |
Chronic hepatitis E with cirrhosis in a kidney-transplant recipient R Gérolami, V Moal, P Colson New England Journal of Medicine 358 (8), 859-860, 2008 | 437 | 2008 |
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: additional analyses from the phase III RESORCE trial RS Finn, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, O Yokosuka, ... Journal of hepatology 69 (2), 353-358, 2018 | 344 | 2018 |
Treatment of severe acute hepatitis E by ribavirin R Gerolami, P Borentain, F Raissouni, A Motte, C Solas, P Colson Journal of clinical virology 52 (1), 60-62, 2011 | 202 | 2011 |
Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies M Bourliere, G Penaranda, C Renou, D Botta‐Fridlund, A Tran, I Portal, ... Journal of viral hepatitis 13 (10), 659-670, 2006 | 178 | 2006 |
RESORCE Investigators Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled … J Bruix, S Qin, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, ... Lancet 389 (10064), 56-66, 2017 | 168 | 2017 |
Autochthonous infections with hepatitis E virus genotype 4, France P Colson, P Romanet, V Moal, P Borentain, R Purgus, A Benezech, ... Emerging infectious diseases 18 (8), 1361, 2012 | 137 | 2012 |
A national survey of acute hepatitis E in France C Renou, X Moreau, A Pariente, JF CADRANEL, E Maringe, T Morin, ... Alimentary pharmacology & therapeutics 27 (11), 1086-1093, 2008 | 133 | 2008 |
Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients C Charpin, S Guis, P Colson, P Borentain, JP Mattéi, P Alcaraz, ... Arthritis research & therapy 11, 1-5, 2009 | 125 | 2009 |
Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients R Gérolami, V Moal, C Picard, P Colson Journal of hepatology 50 (3), 622-624, 2009 | 123 | 2009 |
Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers P Colson, P Borentain, A Motte, M Henry, V Moal, D Botta-Fridlund, ... Virology 367 (1), 30-40, 2007 | 119 | 2007 |
Whipple’s disease: immunospecific and quantitative immunohistochemical study of intestinal biopsy specimens H Lepidi, F Fenollar, R Gerolami, JL Mege, MF Bonzi, M Chappuis, ... Human pathology 34 (6), 589-596, 2003 | 116 | 2003 |
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg‐negative and anti‐HBc antibodies‐positive patients undergoing chemotherapy and/or … P Borentain, P Colson, D Coso, E Bories, A Charbonnier, AM Stoppa, ... Journal of viral hepatitis 17 (11), 807-815, 2010 | 114 | 2010 |
Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats J Faivre, J Clerc, R Gérolami, J Hervé, M Longuet, B Liu, J Roux, F Moal, ... Cancer Research 64 (21), 8045-8051, 2004 | 112 | 2004 |
Quantitative Detection of Tropheryma whipplei DNA by Real-Time PCR F Fenollar, PE Fournier, D Raoult, R Gérolami, H Lepidi, C Poyart Journal of clinical microbiology 40 (3), 1119-1120, 2002 | 100 | 2002 |
Clinical phenotype and outcome of hepatitis E virus–associated neuralgic amyotrophy JJJ Van Eijk, HR Dalton, P Ripellino, RG Madden, C Jones, M Fritz, ... Neurology 89 (9), 909-917, 2017 | 93 | 2017 |
Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: the … R Bilbao, R Gérolami, MP Bralet, C Qian, PL Tran, B Tennant, J Prieto, ... Cancer Gene Therapy 7 (5), 657-662, 2000 | 93 | 2000 |
Treatment of autochthonous acute hepatitis E with short‐term ribavirin: a multicenter retrospective study JM Péron, F Abravanel, M Guillaume, R Gérolami, J Nana, R Anty, ... Liver International 36 (3), 328-333, 2016 | 91 | 2016 |